Atlas Trials

Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Clinical trial NCT00288067 · TERMINATED

Trial details

NCT number
NCT00288067
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Adult Nodular Lymphocyte Predominant Hodgkin LymphomaB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Burkitt LymphomaContiguous Stage II Adult Diffuse Large Cell LymphomaContiguous Stage II Adult Lymphoblastic LymphomaContiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular LymphomaContiguous Stage II Mantle Cell LymphomaStage II Marginal Zone LymphomaStage II Small Lymphocytic LymphomaExtranodal Marginal Zone B-cell LymphomaNodal Marginal Zone B-cell Lymphoma
Start date
2005-10-01
Primary completion
2013-07-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.